RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment

Radiation therapy is a staple approach for cancer treatment, whereas radioresistance of cancer cells remains a substantial clinical problem. In response to ionizing radiation (IR) induced DNA-damage, cancer cells can sustain/activate pro-survival signaling pathways, leading to apoptotic resistance a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncogene
Egile Nagusiak: Hein, Ashley L., Post, Carl M., Sheinin, Yuri M., Lakshmanan, Imayavaramban, Natarajan, Amarnath, Enke, Charles A., Batra, Surinder K., Ouellette, Michel M., Yan, Ying
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112160/
https://ncbi.nlm.nih.gov/pubmed/27181206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.163
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak